Cha Biotech to Acquire Additional Cha Healthcare Shares for 153.9 Billion Won
Cha Biotech announced on June 26 that it will acquire an additional 5,919,732 shares of Cha Healthcare, its overseas healthcare network operation and investment development subsidiary, for approximately 153.9 billion won. After the acquisition, Cha Biotech's stake in Cha Healthcare will increase to 81.7%.
Hot Picks Today
Karina Fetches 6.7 Billion Won, Lives Under 24-Hour Armed Guard... World's Most Expensive Cow in the Spotlight
- "If It Breaks, That's It": Chaos Among Samsung and SK hynix Consumers... Soaring SSD Prices Mean "No Replacement, Only Refund at Original Price"
- "I'll Pay with Both Shares and Cash" vs "Cash Only"... Why Chey Taewon Filed a Further Appeal After Careful Deliberation
- Yu In-chon: "Even Sadder Than Last Year"...Bicycle Pilgrimage to Mark Brother's First Anniversary
- Do Night Runners Need Sunscreen? MFDS Says "UV from Streetlights Has Minimal Impact"
Cha Biotech explained that this share acquisition is "a precedent condition under the share purchase agreement to transfer part of the shares held in our subsidiary, Cha Healthcare Co., Ltd., to the PiumAI Future Healthcare Fund."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
